Newsroom
Sorted by: Latest
-
Verdant Rock獲得Morningstar DBRS給予的A(低)財務實力評等,新增第二項國際投資級評估
百慕達漢彌頓--(BUSINESS WIRE)--(美國商業資訊)-- 受百慕達金融管理局監管的3B類保險公司Verdant Rock Limited已獲得Morningstar DBRS給予的A(低)財務實力評等。該評等反映了Verdant Rock的財務實力,以及其身為新興市場信用之投資級財務擔保人履行保單持有人義務的能力。 Morningstar DBRS是一家全球信用評等機構,業務涵蓋北美、歐洲、亞洲和拉丁美洲。其對Verdant Rock的評估體現了該公司強勁的預計獲利能力、穩健的風險狀況、良好的流動性以及充足的資本水準。Morningstar DBRS同時向Verdant Rock給予A(低)發行人評等。此前,Fitch Ratings已於2026年6月12日向Verdant Rock給予BBB+長期保險公司財務實力評等(展望穩定)。至此,Verdant Rock已同時持有Fitch Ratings和Morningstar DBRS給予的財務實力評等,為交易對手提供了雙機構對其投資級地位的確證。 Verdant Rock的擔保產品針對具有投資級配置要求的受益人設計。持有Ve...
-
Tecnotree wurde im ersten Gartner® Magic Quadrant™ 2026 for CSP AI-Enabled Marketing and Sales Solutions als Visionary ausgezeichnet
ESPOO, Finnland--(BUSINESS WIRE)--Tecnotree, ein Weltmarktführer für digitale Plattformen und Dienstleistungen für KI, 5G und Cloud-native Technologien, gab heute bekannt, dass Gartner das Unternehmen im ersten Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions als Visionary eingestuft hat. Eine neue Kategorie für ein neues Betriebsmodell. CSPs sind mit gesättigten Märkten, steigenden Akquisitionskosten und einer zunehmenden Kundenabwanderung konfrontiert. Sie reagieren darauf mit...
-
Exchange Income Corporation to Host Third Quarter Results Conference Call on November 13, 2026
WINNIPEG, Manitoba--(BUSINESS WIRE)--Exchange Income Corporation to Host Third Quarter Results Conference Call on November 13, 2026...
-
Cresco Labs Announces Filing of Supplement to Management Information Circular for Annual General and Special Meeting
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company") today announced that it has filed a supplement (the "Supplement") to its management information circular dated September 18, 2026 (the "Circular") in connection with its annual general and special meeting of shareholders to be held on October 30, 2026. The Supplement enhances and clarifies the disclosure in the Circular concerning the proposed amendment to Cresco's super-voting shares a...
-
JPMorganChase to Present at the BancAnalysts Association of Boston Conference
NEW YORK--(BUSINESS WIRE)--Charles Bristow, Head of Treasury and Chief Investment Officer, will present at the BancAnalysts Association of Boston Conference on Thursday, November 5, 2026 at 8:50 a.m. (Eastern). A live audio webcast will be available on the day of the conference at www.jpmorganchase.com under Investor Relations, Events & Presentations. JPMorgan Chase & Co. (NYSE: JPM) is a leading financial services firm based in the United States of America (“U.S.”), with operations wor...
-
Absolute Security Acquires Phoenix Technologies’ FirmGuard to Build on the Firmware Foundation Enterprises Need for Secure, Compliant, and Resilient AI
SEATTLE--(BUSINESS WIRE)--Absolute Security, a leader in Autonomous Cyber Resilience, today announced it has acquired Phoenix Technologies’ FirmGuard, a UEFI BIOS firmware security, management, and networking service. FirmGuard extends Absolute Persistence®, the patented firmware-embedded technology behind the Autonomous Cyber Resilience Platform. It adds deeper visibility, integrity verification, posture management, continuous patching, and compliance enforcement for endpoints, AI workstations...
-
Verdant Rock recebe classificação de solidez financeira A (baixa) da Morningstar DBRS, adicionando uma segunda avaliação internacional de grau de investimento
HAMILTON, Bermudas--(BUSINESS WIRE)--A Verdant Rock Limited, uma seguradora Classe 3B regulamentada pela Autoridade Monetária das Bermudas, recebeu uma classificação de solidez financeira A (baixa) da Morningstar DBRS. A classificação reflete a solidez financeira da Verdant Rock e sua capacidade de cumprir obrigações com segurados na qualidade de garantidora financeira com grau de investimento para crédito em Mercados Emergentes. A Morningstar DBRS é uma agência global de classificação de risco...
-
Arcus Biosciences Announces New Employment Inducement Grants
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for the treatment of cancer and inflammatory diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted 2 new employees options to purchase a total of 9,150 shares of the Company’s common stock at an exercise price per share of $23.83, which was the closing pric...
-
Investor Alert: Robbins LLP Informs Investors of The Chemours Company Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is investigating whether Chemours materially overstated market demand for its products....
-
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2026 Financial Results
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American, Symbol: CCEL) (the “Company”, “Cryo-Cell”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2026. Financial Results Revenue Consolidated revenues for the third quarter of fiscal 2026 were $7.82 million compared to $7.83 million for the third quarter of fiscal 2025. Net Income The Company reported net income of $1.27 mil...